|
CHANTIX NEWS
• Stop-Smoking therapy: risky in pregnancy
• St. Mary's Healthcare Center Employees Complete
12-Week Lasting Quit Smoking Program
• Nicotine Addictive Effects Emerge As Powerful
As Cocaine and Heroin
• Research Evaluates Chantix As More Effective
Than Zyban
• Chantix Wins the Award for the Best New Small-Molecule
Drug
• Europe Approves the New Anti-Smoking Drug
Champix (Varenicline)
.............................................
Stop-Smoking therapy: risky in pregnancy
Sept 27, 2007
According to a new study, nicotine replacement gum, patches
or lozenges are widely used by pregnant smokers to quit smoking.
The researcher says, these therapies must have some benefits
but also there are some drawbacks like premature delivery
or early birth.
The author of American Journal of Preventive Medicine noted
that an independent safety board suspended recruitment for
the study due to health problems among women. These women
were taking nicotine replacement therapy and the result was
premature delivery at about 36 weeks.
Kathryn Pollak, associate professor at Duke University Medical
Center, in Durham, N.C., said "Every pregnant woman wants
to quit smoking. Every woman knows it's bad for her baby,"
The research on 181 female smokers was done in their second
trimester of pregnancy. The smokers were treated with cognitive
behavioral therapy, including in-person and telephone counseling
sessions, to help them quitting smoking. The choice to make
use of nicotine replacement therapy in the form of gum, patches
or lozenges was offered to 122 women.
Women cotinine saliva levels were analyzed by researchers
to conclude their smoking status. After seven weeks 25 percent
of women had quit. 18 percent of the women using nicotine
replacement therapies remained smoke-free at 38 weeks of conception.
Babies whose mothers smoke are 30 percent more likely to
be born prematurely, according to the U.S. Centers for Disease
Control and Prevention.
[ top ]
.............................................
St. Mary's Healthcare Center Employees Complete
12-Week Lasting Quit Smoking Program
Date: 25th May 2007
Workers at St. Mary's Healthcare Center have just completed
a quit smoking programme that lasted for 12 weeks. It is further
known that altogether 77 smokers have enthusiastically taken
part in the smoking cessation initiative with Chantix, the
drug to induce smoking cessation which was supplied for free
among the participants.
Even though the exact amount of people who have induced smoking
cessation at the St. Mary's Healthcare Center is not known,
Steve Case, a pharmacist at St. Mary's and the support group
facilitator expects the number of quitters to lie between
30 and 35.
Regarding the quit smoking program, Steve Case expresses
hope that it may further expand to another local business
in the future. He reveals that the quit smoking support group
is interested in involving a large business in town having
a significant amount of smokers with the program. Relating
to this new venture, Steve Case is hopeful that in this way
the program can branch out to a larger section of people.
As the smoking cessation program draws to a close, a program
participant Joe Peterson makes it clear that after quitting
smoking, he and the other participants have achieved a tremendous
sense of accomplishment.
Further, it is known that the number of people completing
the program have been offered attractive freebies. The incentives
provided to the quitters include summer long membership discount
offered by Oahe YMCA and considerable discount on one pair
of shoes by Foot Locker and Capital City Sports. Altogether,
free food supplied by Domino's pizza to the participants for
the celebration of the graduation ceremony.
Source: www.capjournal.com
[ top ]
.............................................
Nicotine Addictive Effects Emerge As Powerful
As Cocaine and Heroin
Date: 30 th April 2007
It is no longer a secret that the addiction of nicotine is
potent like cocaine and heroin and the validity of this fact
has been strengthened by a 618-page report prepared on May
17, 1988, 19 years ago by Surgeon General C. Edward Coop that
emphasized that cigarette addiction is potent like cocaine
and heroine. The report by Surgeon General C. Edward Coop
further concludes that the behavioral and pharmacological
processes that led to the determination of tobacco addiction
are very similar to the processes that determine the addiction
to heroin and cocaine.
The powerful effects of nicotine addiction can be gauged
from the story of Henry W. "Chuck" Richardson; a
man who was earlier addicted to heroin, gave it up but consequently
fell in the grip of cigarette addiction. It is indeed astonishing
that Henry W. "Chuck" Richardson successfully got
rid of heroin addiction after taking the drug on a continuous
basis for 23 years, but when it came to bid goodbye to the
addiction of cigarettes the Marine machine gunner with two
Purple Hearts and the Vietnamese Cross of Gallantry pathetically
failed.
Source: www.blackpressusa.com
[ top ]
.............................................
Research Evaluates Chantix As More Effective
Than Zyban
February 25, 2007
Researcher David Gonzales and his associates administered
the quit smoking medicines Chantix and Zyban on more than
1000 smokers and derived the conclusion that the quit smoking
medication Chantix is more efficient than Zyban.
As the experiments ended, it became evident that in comparison
to the 18 percent people quitting smoking right away through
Zyban and 10 percent through placebo, a large amount of people,
around 20 percent had induced smoking cessation by administering
the anti-smoking medicine Chantix .
Chantix is an anti-smoking drug that reduces the nicotine
cravings in the brain while Zyban is an anti-depressant and
the doctors experimented these medicines on smokers within
the period June 2003 to April 2005.
The details of the experiment were presented at a summit
of the Society for Research on Nicotine and Tobacco in Austin
, Texas .
Source: www.news-medical.net
[ top ]
.............................................
Chantix Wins the Award for the Best New
Small-Molecule Drug
November 16, 2006
Pfizer's smoking cessation product Chantix wins the Scrip
Award for the Best New Small-Molecule Drug.
The second Scrip Awards ceremony was held at the Grosvenor
House Hotel in London on November 16, 2006 which was hosted
by Gyles Brandreth, the celebrity, author and politician.
The Scrip Award is a way to acknowledge the exceptionally
significant chore of the pharmaceutical industry to the human
civilization.
More than 600 international guests were present at the eve
of the second Scrip Award Ceremony including the representatives
and scientists from all pharmaceutical giants.
Source: PRNewswire
[ top ]
.............................................
Europe Approves the New Anti-Smoking Drug
Champix (Varenicline)
September 29, 2006
Pfizer Inc. announced the approval of Champix/
Varenicline by the European regulators as a treatment for
smoking cessation.
The new anti-smoking drug Varenicline was already
recommended for approval by the European medical experts in
the month of July, soon after the approval by the U.S. Food
and Drug Administration in June this year.
The drug Champix, which is known as Chantix in
the U.S. will soon be available in the chemist shops and pharmacies.
According to Richard Simpson, the marketing in charge of Varenicline
in Europe , the medicine will be available in shops by early
2007.
Source: reuters.com
[ top ]
|
